"","V1","V2","V3","V4","V5","V6","V7","V8","V9","V10","V11","V12","V13","V14","V15","V16","V17","V18","V19","V20","V21","V22","V23","V24","V25","V26","V27","V28","V29","V30","V31","V32","V33","V34","V35","V36","V37","V38","V39","V40","V41","V42","V43","V44","V45","V46","V47","V48","V49","V50","V51","V52","V53","V54","V55","V56","V57","V58","V59","V60","V61","V62","V63","V64","V65","V66","V67","V68","V69","V70","V71","V72","V73","V74","V75","V76","V77","V78","V79","V80","V81","V82","V83","V84","V85","V86","V87","V88","V89","V90","V91","V92","V93","V94"
"1","abs158.txt","checkpoint","immunotherapy","uses","highly","selective","humanized","monoclonal","antibodiesagainst","signals","such","as","programmed","cell","death","receptor","(pd-1)","andprogrammed","ligand","(pd-l1)","","by","blocking","these","receptors","and","the","immune","system","can","be","reactivated","to","fight","tumor","foradvanced","non-small","lung","cancer","(nsclc)","has","resulted","in","a","new","paradigm","oftreatment","options","resulting","improved","survival","response","rates","aless","severe","yet","unique","toxicity","profile","when","compared","chemotherapy","pd-1inhibitors","nivolumab","pembrolizumab","pd-l1","inhibitor","atezolizumab","arecurrently","approved","regulatory","authorities","for","treatment","of","advanced","nsclc","this","article","provides","detailed","review","newer","agents","their","mechanism","ofaction","side-effect","therapeutic","indications","current","evidencesupporting","use","management"
